Since the Supreme Court overturned Roe v. Wade in 2022, mifepristone has become the focal point of current abortion debates, and now, the FDA itself is may be moving to restrict or eliminate access to this safe, widely used medication. The FDA, under influence from the US Health and Human Services Secretary RFK Jr., has […]| Feminist Majority Foundation
The overturning of Roe v. Wade three years ago has had far-reaching consequences beyond restricting access to abortion. As outlined in a report by the National Abortion Federation (NAF), there has been a drastic increase in violence against abortion providers, including but not limited to arson, burglaries, and death threats. Since Dobbs v. Jackson Women’s […]| Feminist Majority Foundation